Business context and reporting period
Entity and period: The supplied filing is Rosecliff Acquisition Corp I’s Form 10-K for the fiscal year ended December 31, 2021—not a Spectral AI, Inc. filing and not a quarterly report. Rosecliff was a shell company/SPAC with no operating business or operating revenue; its activity was raising capital and seeking a business combination.
Rosecliff completed its February 2021 IPO of 25.3 million units at $10 per unit, raising $253.0 million gross, and sold $7.06 million of private placement warrants. It had until February 17, 2023 to complete a business combination or liquidate.
Financial highlights
| Metric | FY 2021 / Dec. 31, 2021 |
|---|---|
| Operating revenue | None |
| General and administrative expenses / operating loss | $3.42 million |
| Net loss | $2.15 million; basic and diluted loss per share was $0.08 for both share classes |
| Other income, net | $1.27 million, including a $1.68 million warrant fair-value gain, offset by $438,283 of warrant-related transaction costs; trust interest was $27,240 |
| Cash from operating activities | Used $825,593 |
| Cash and prepaid expenses | $769,432 cash; $313,125 prepaid expenses |
| Trust Account | $253.03 million, invested in U.S. Treasury-related funds and restricted primarily for a business combination or shareholder redemptions |
| Liabilities | $21.93 million total, including $10.14 million warrant liabilities and $8.86 million deferred underwriting fees |
| Debt and liquidity | No long-term debt reported; $16,152 due to Sponsor. Management said available liquidity might not cover working-capital needs through the deadline. |
Margins are not meaningful because the company had no operating revenue. The reported warrant gain was non-cash and resulted from recurring fair-value accounting, so reported earnings can fluctuate without corresponding operating cash flows.
Changes versus the prior comparable period
FY 2021 was the first full year and included the IPO, trust funding and target search; the comparator is only the period from incorporation on November 17, 2020 through December 31, 2020. The company reported a $675 net loss in that short 2020 period, versus a $2.15 million loss in 2021. It reported no operating cash use in the 2020 period, compared with $825,593 used in 2021. These periods are not directly comparable.
After year-end, on March 11, 2022, Rosecliff and the parties to its previously announced business combination agreement with Gett mutually terminated the agreement. The filing says the parties ended discussions after reviewing the target’s projections and negotiating a valuation adjustment. Rosecliff said it would continue seeking a target.
Outlook, risks and unusual items
- Going concern: Management and the auditor cited substantial doubt about Rosecliff’s ability to continue as a going concern, given the business-combination deadline, uncertain ability to complete a transaction and possible shortfall in working-capital liquidity. Additional funding from the Sponsor or others was possible but not committed.
- Liquidation exposure: If no combination is completed by the deadline, public shares are to be redeemed from the Trust Account, subject to creditor claims and other conditions; warrants would expire worthless. The redemption amount could be below $10 per share.
- Controls: Management concluded disclosure controls were ineffective because of a material weakness in accounting for complex financial instruments. Remediation steps were described, but effectiveness was not established in the filing. The auditor did not attest to internal controls.
- Warrant accounting: Warrants were recorded as liabilities and remeasured at fair value through earnings. This produced a material non-cash gain in 2021 and can cause future earnings volatility.
- Other risks: The filing highlights competition for SPAC targets, redemption and financing uncertainty, potential dilution and conflicts of interest involving the Sponsor and management, as well as claims that could reduce Trust Account proceeds. It reports no material legal proceedings.
- Outlook: No financial guidance or operating forecast is provided. Management’s stated plan was to continue pursuing an appropriate business combination.
Important facts for investors to verify
- Confirm the issuer: this document is for Rosecliff Acquisition Corp I, not Spectral AI, Inc.
- Review the subsequent-event disclosure and related filings for the termination of the Gett transaction and any later target, extension, redemption or liquidation developments.
- Verify the business-combination deadline: the filing repeatedly states February 17, 2023, but one passage in the financial-statement discussion says February 17, 2022, an apparent inconsistency.
- Assess the status and remediation of the material weakness, and whether later filings report effective controls or any restatement.
- Check current Trust Account assets, cash available outside the Trust, accrued expenses, deferred underwriting fees and any Sponsor or third-party financing.
- Review warrant terms and the impact of fair-value changes, dilution, redemptions and any outstanding claims on per-share value.